Glutamine supplementation for young infants with severe gastrointestinal disease.

ABSTRACT:

Background

Endogenous glutamine biosynthesis may be insufficient to meet the needs of people with severe gastrointestinal disease. Results from studies using experimental animal models of gastrointestinal disease have suggested that glutamine supplementation improves clinical outcomes. This review examines evidence on the effect of glutamine supplementation in young infants with severe gastrointestinal disease.

Objectives

To assess the effect of supplemental glutamine on mortality and morbidity in young infants with severe gastrointestinal disease.

Search methods

We searcheed the Cochrane Central Register of Controlled Trials (The Cochrane Library, 2014, Issue 8), MEDLINE, EMBASE, and CINAHL (from inception to September 2014), conference proceedings, and reference lis

SUBMITTER: Brown JV 

PROVIDER: S-EPMC10082939 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature